Metraipolis › archive › dc_a5caa11adfd7

Osteopontin-4 (OPN-4) Suppresses Tumor Progression Features Whilst Sensitizing c643 Anaplastic Thyroid Cells to Sorafenib — Europe PMC PMID:42193316

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42193316
DOI
10.3390/biomedicines14050989
License (as archived)
solo-consultazione
Archived
2026-11-03T06:33:20.675Z
SHA-256 of the archived text
2011bfe84e8049b5c295c6ba131ae1d13d3fed7d07413b3cca1b42ae3afeb6e2
Stable URL of this page
https://metraipolis.com/documento/dc_a5caa11adfd7

How to cite

Osteopontin-4 (OPN-4) Suppresses Tumor Progression Features Whilst Sensitizing c643 Anaplastic Thyroid Cells to Sorafenib — Europe PMC PMID:42193316 — Europe PMC (en), https://europepmc.org/article/MED/42193316 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_a5caa11adfd7 (Metraipolis archive dc_a5caa11adfd7, sha256 2011bfe84e8049b5c295c6ba131ae1d13d3fed7d07413b3cca1b42ae3afeb6e2)
BibTeX
@misc{dca5caa11adfd7,
  title = {Osteopontin-4 (OPN-4) Suppresses Tumor Progression Features Whilst Sensitizing c643 Anaplastic Thyroid Cells to Sorafenib — Europe PMC PMID:42193316},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42193316},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_a5caa11adfd7; sha256 2011bfe84e8049b5c295c6ba131ae1d13d3fed7d07413b3cca1b42ae3afeb6e2},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42193316. Agents can read the archived copy with the MCP tool read_document.